1 |
Chau BN, Brenner DA (2010). What goes up must come down: The emerging role of microrna in fibrosis. Hepatology, 53, 4-6.
|
2 |
Chen A, Xu J, Johnson AC (2006). Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene, 25, 278-87.
DOI
|
3 |
Chen X, Murad M, Cui YY, et al (2011). Mirna regulation of liver growth after 50% partial hepatectomy and small size grafts in rats. Transplantation, 91, 293-9.
DOI
|
4 |
Choudhuri T, Pal S, Das T, Sa G (2005). Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem, 280, 20059-68.
DOI
|
5 |
Dorai T, Dutcher JP, Dempster DW, Wiernik PH (2004). Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells. Prostate, 60, 1-17.
DOI
|
6 |
Huang MT, Lou YR, Ma W, et al (1994). Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res, 54, 5841-7.
|
7 |
Kim S, Lee UJ, Kim MN, et al. (2008) MicroRNA miR-199a* regulates the MET proto-oncogene and the downstream extracellular signal-regulated kinase 2 (ERK2). J Biol Chem, 283, 18158-66.
DOI
|
8 |
Li WQ, Chen C, Xu MD, et al (2011). The rno-mir-34 family is upregulated and targets acsl1 in dimethylnitrosamineinduced hepatic fibrosis in rats. FEBS J, 278, 1522-32.
DOI
ScienceOn
|
9 |
Maheshwari RK, Singh AK, Gaddipati J, Srimal RC (2006). Multiple biological activities of curcumin: a short review. Life Sci, 78, 2081-7.
DOI
|
10 |
Murakami Y, Yasuda T, Saigo K, et al. (2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene, 25, 2537-45.
DOI
ScienceOn
|
11 |
Murakami Y, Toyoda H, Tanaka M, et al (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One, 6, 16081.
DOI
|
12 |
Nagata H, Hatano E, Tada M, et al (2009). Inhibition of c-jun nh2-terminal kinase switches smad3 signaling from oncogenesis to tumor-suppression in rat hepatocellular carcinoma. Hepatology, 49, 1944-53.
DOI
|
13 |
Perkins S, Verschoyle RD, Hill K, et al (2002). Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev, 11, 535-40.
|
14 |
Yuan B, Dong R, Shi D, et al (2011). Down-regulation of mir-23b may contribute to activation of the tgf-beta1/smad3 signalling pathway during the termination stage of liver regeneration. FEBS Lett, 585, 927-34.
DOI
|
15 |
Roderburg C, Urban GW, Bettermann K, et al (????). Micro-rna profiling reveals a role for mir-29 in human and murine liver fibrosis. Hepatology, 53, 209-18.
|
16 |
Shishodia S, Chaturvedi MM, Aggarwal BB (2007). Role of curcumin in cancer therapy. Curr Probl Cancer, 31, 243-305.
DOI
|
17 |
Yang N, Mahato RI (2011). Gfap promoter-driven rna interference on tgf-beta1 to treat liver fibrosis. Pharm Res, 28, 752-61.
DOI
|